Vaccination with Nontoxic Mutant Toxic Shock Syndrome Toxin 1 Protects againstStaphylococcus aureusInfection

Citations Over TimeTop 11% of 2003 papers

Abstract

To investigate whether vaccination with nontoxic mutant toxic shock syndrome toxin 1 (mTSST-1) can protect against Staphylococcus aureus infection, mice were vaccinated with mTSST-1 and challenged with viable S. aureus. Survival in the mTSST-1-vaccinated group was higher, and bacterial counts in organs were significantly lower than those of control mice. Passive transfer of mTSST-1-specific antibodies also provided protection against S. aureus-induced septic death. Interferon (IFN)-gamma production in the serum samples and spleens from vaccinated mice was significantly decreased compared with that in controls, whereas interleukin-10 titers were significantly higher in vaccinated mice. IFN-gamma and tumor necrosis factor-alpha production in vitro were significantly inhibited by serum samples from mTSST-1-immunized mice but not from control mice. These results suggest that vaccination with mTSST-1 devoid of superantigenic properties provides protection against S. aureus infection and that the protection might be mediated by TSST-1-neutralizing antibodies as well as by the down-regulation of IFN-gamma production.

Related Papers

• → In-Vitro Studies of Interactions Between Tampons and Staphylococcus aureus(1982)23 cited
• → Production of Toxic Shock Syndrome Toxin 1 in a Mouse Model of Staphylococcus aureus Abscess Formation(1989)5 cited
• → Infection with Staphylococcus aureus producing toxic shock syndrome (TSS) toxin-1 without TSS(1989)3 cited
• Identifikasi Gen Penyandi Toxic shock syndrome toxin-1 (TSST-1) Staphylococcus aureus dari Susu Sapi Perah Penderita Mastitis(2010)